Live Breaking News & Updates on Fulcrum Therapeutics
Stay updated with breaking news from Fulcrum therapeutics. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Cytokinetics (NASDAQ:CYTK – Get Free Report) and Fulcrum Therapeutics (NASDAQ:FULC – Get Free Report) are both medical companies, but which is the superior investment? We will compare the two businesses based on the strength of their institutional ownership, dividends, risk, earnings, profitability, analyst recommendations and valuation. Analyst Ratings This is a breakdown of current recommendations […] ....
Fulcrum Therapeutics, Inc. (NASDAQ:FULC – Free Report) – Equities researchers at Cantor Fitzgerald issued their FY2024 EPS estimates for shares of Fulcrum Therapeutics in a note issued to investors on Monday, May 20th. Cantor Fitzgerald analyst K. Kluska forecasts that the company will earn ($0.78) per share for the year. Cantor Fitzgerald currently has a […] ....
Fulcrum Therapeutics, Inc. (NASDAQ:FULC – Get Free Report) was the target of unusually large options trading on Tuesday. Stock investors bought 9,544 call options on the company. This represents an increase of approximately 867% compared to the typical volume of 987 call options. Fulcrum Therapeutics Stock Down 0.8 % FULC stock opened at $7.64 on […] ....
Fulcrum Therapeutics, Inc. (NASDAQ:FULC – Get Free Report) was the target of unusually large options trading activity on Tuesday. Traders bought 9,544 call options on the stock. This represents an increase of 867% compared to the average daily volume of 987 call options. Insider Buying and Selling In other Fulcrum Therapeutics news, VP Greg Tourangeau […] ....
Equities Research Analysts' New Coverage for May 20th (ABVX, AISP, ALLT, AZZ, BGI, BGSF, BIOL, BY, CETX, CLF) dailypolitical.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from dailypolitical.com Daily Mail and Mail on Sunday newspapers.